Breast Cancer Mortality Rate 2008
Worldwide, breast cancer is the second most common type of cancer after lung cancer. Breast Cancer Mortality Rate 2008Experts all over the world have made great progress in treating cancer. It can often be cured if it is found early and it is not always necessary to remove the breast.
The earliest stages of it have no symptoms because the clumps of cancer cells are too small to be felt. The most common symptom is a painless lump or thickening in the breast. More than 80% of this disease cases are discovered when the woman feels a lump. It can also cause a change in the way it looks, the skin of the breast may dimple. There may also be a change in the size or shape of it, change in the nipple, or a clear or bloody fluid that comes out of the nipple. Pain is an unreliable tool in determining the presence or absence of it, but may be indicative of other breast-related health issues such as mastodynia.
When cells invade the dermal lymphatics, small lymph vessels in the skin of the breast, its presentation can resemble skin inflammation and thus is known as inflammatory breast cancer (IBC). This type is less common than ductal or lobular breast cancer. It is an advanced, aggressive form of cancer, which is usually not detected by a mammogram or an ultrasound. Signs of inflammatory cancer include pain, swelling, warmth and redness throughout the breast and an orange peel texture to the skin.
Reported symptom of complex breast cancer is Paget’s disease of the breast. It is a condition that outwardly may have the appearance of eczema – with skin changes involving the nipple. Because of its seemingly innocuous and surface appearance, it often presents late, but it is a condition that may be fatal.
Metastatic cancer or Stage 4 is diagnosed when cells from the original breast tumor have spread to other parts of your body. It is estimated that nearly 155,000 women in the U.S. are currently living with metastatic breast cancer This will cause symptoms that depend on the location of metastasis.
Common sites of metastasis include bone, liver, lung and brain. Signs of fevers or chills and unexplained weight loss can be a symptom of metastatic cancer. Bone or joint pains can sometimes be manifestations of metastatic breast cancer, as can jaundice or neurological symptoms.
Over 350 non-toxic natural and alternative treatments that have helped thousands of people beat their cancer. Over 2,000 testimonials! Success rates for surgery, chemo and Radiation revealed! Free information on financial and other help available. Download this set of 4 e-Books and Reports NOW. It could save your life.
Lung Cancer Secrets Revealed Click here
Worldwide, breast cancer is the second most common type of cancer after lung cancer. Experts all over the world have made great progress in treating cancer. It can often be cured if it is found early and it is not always necessary to remove the breast.
The earliest stages of it have no symptoms because the clumps of cancer cells are too small to be felt. The most common symptom is a painless lump or thickening in the breast. More than 80% of this disease cases are discovered when the woman feels a lump. It can also cause a change in the way it looks, the skin of the breast may dimple. There may also be a change in the size or shape of it, change in the nipple, or a clear or bloody fluid that comes out of the nipple. Pain is an unreliable tool in determining the presence or absence of it, but may be indicative of other breast-related health issues such as mastodynia.
When cells invade the dermal lymphatics, small lymph vessels in the skin of the breast, its presentation can resemble skin inflammation and thus is known as inflammatory breast cancer (IBC). This type is less common than ductal or lobular breast cancer. It is an advanced, aggressive form of cancer, which is usually not detected by a mammogram or an ultrasound. Signs of inflammatory cancer include pain, swelling, warmth and redness throughout the breast and an orange peel texture to the skin.
Reported symptom of complex breast cancer is Paget’s disease of the breast. It is a condition that outwardly may have the appearance of eczema – with skin changes involving the nipple. Because of its seemingly innocuous and surface appearance, it often presents late, but it is a condition that may be fatal.
Metastatic cancer or Stage 4 is diagnosed when cells from the original breast tumor have spread to other parts of your body. It is estimated that nearly 155,000 women in the U.S. are currently living with metastatic breast cancer This will cause symptoms that depend on the location of metastasis.
Common sites of metastasis include bone, liver, lung and brain. Signs of fevers or chills and unexplained weight loss can be a symptom of metastatic cancer. Bone or joint pains can sometimes be manifestations of metastatic breast cancer, as can jaundice or neurological symptoms.
Over 350 non-toxic natural and alternative treatments that have helped thousands of people beat their cancer. Over 2,000 testimonials! Success rates for surgery, chemo and radiation revealed! Free information on financial and other help available. Download this set of 4 e-Books and Reports NOW. It could save your life.
lung cancer treatment breakthroughs Click here
About the Author
lung cancer best treatment Click here
Breast Cancer with Metastases to the Liver, Lung and Bones
|
|
Breast Cancer Husband: How to Help Your Wife (and Yourself) during Diagnosis, Treatment and Beyond $3.95 A unique guide, like none other on the market-packed with medical information, practical tips, psychological insight, and coping strategies-to help men help the women they love through this trying time.When Marc Silver became a breast cancer husband three years ago, he learned firsthand how frightened and helpless the breast cancer husband feels. He searched in vain for a book that would give him … |
|
|
Dr. Susan Love’s Breast Book $2.61 The landscape of breast cancer has changed. New, non-invasive diagnostic techniques, new knowledge about prevention, new genetics, new treatments, new alternative and complementary resources are beginning to turn breast cancer into a chronic and perhaps preventable disease. Dr. Susan Love, whose earlier work has won the trust of women all over this country and abroad, has entirely revised her indi… |
|
|
The Cancer Recovery Eating Plan: The Right Foods to Help Fuel Your Recovery $4.95 Dr. Nixon, editor-in-chief of the journal Cancer Prevention, cuts through the hype to explain the latest scientific findings on food and cancer. He presents individualized eating plans according to the type of cancer and offers a three-month plan to benefit the person with cancer. Over 100 recipes help put the plan into action…. |
|
|
Handbook of Metastatic Breast Cancer $149.95 There used to be limited therapeutic options for women who developed metastatic breast cancer. However, developments with systemic drugs and palliative surgical techniques, together with advances in diagnostic imaging, have given new hope for these patients. This book looks at different areas in the treatment of breast cancer. |
|
|
Handbook of Metastatic Breast Cancer, Second Edition $170 There used to be limited therapeutic options for women who developed metastatic breast cancer. However, recent development with novel systemic drugs and palliative surgical techniques, together with advances in diagnostic imaging, have given new hope for these patients and made the treatment of these patients considerably more challenging. One convenient source bringing together the various relevant aspects is long overdue. This handbook covers treatment for both the cancer and the complications that can arise from treatment itself. |
|
|
ABC of Breast Diseases $56.95 Breast diseases are becoming much more common: health professionals in almost every field will probably come into contact with a patient who has a breast disorder. This third edition provides an up-to-date account of benign and malignant breast conditions and the treatment of them. It covers all the recent advances in screening and adjuvant treatment, including the new aromatase inhibitor trials and improvements in metastatic disease treatment. New chapters on prognosis and clinical trials have also been added.The chapters include:Symptoms, assessment, and guidelines for referralCongenital problems and aberrations of normal breast development and involutionMastalgiaBreast infectionBreast cancer—epidemiology, risk factors, and geneticsScreening for breast cancerBreast cancerManagement of regional nodes in breast cancerBreast cancer—treatment of elderly patients and uncommon conditionsRole of systemic treatment for primary operable breast cancerLocally advanced breast cancerMetastatic breast cancerPrognostic factorsClinical trials of management of early breast cancerPsychological aspectsCarcinoma in situ and patients at high risk of breast cancerBreast reconstructionEdited and written by experts in the field, this book appeals to a wide readership including general practitioners, practice nurses, breast care nurses, surgeons or oncologists in training, and medical students. Its wealth of knowledge will also be a valuable source of information for established breast surgeons and oncologists. It will also help the assessment of symptoms, prognosis and treatments of breast diseases. |
|
|
Advanced Breast Cancer $19.95 New – Dealing with the realities of living with metastatic disease, this text offers hope and comfort. All aspects of facing the disease are covered, including: coping with the shock of recurrence; seeking information and making treatment decisions; communicating effectively with medical personnel; finding support; and handling disease progression and end-of-life issues. It also provides resources and treatment developments, including novel formulation of conventional drugs, as well as the lates |
|
|
Bmi-1 collaborates with H-Ras to promote mammary epithelial cell transformation, tumorigenesis, and metastasis. $49.99 The polycomb group protein Bmi-1 is a transcription repressor reported to regulate self-renewal of normal and cancer stem cells, and prevent cellular senescence through inhibition of cyclin-dependent kinase inhibitors pi6lnk4a and p19Arf. Originally discovered as a cooperating oncogene with c-Myc in a murine model of leukemia, overexpression of Bmi-1 has since been reported in several forms of cancer, including breast cancer. A direct or collaborative role of Bmi-1 in the pathogenesis of breast cancer would be critical in the development of novel biomarkers for diagnosis and treatment of this disease. We demonstrate that overexpression of Bmi-1 alone and in combination with H-Ras in normal mammary epithelial cells (MCF10A) markedly changes cellular morphology, increases proliferative indices, and decreases the apoptotic response to apoptosis-inducing agents in vitro. Our data also suggests that overexpression of Bmi-1 confers stem cell-like properties, including the formation of spheroid structures resembling mammospheres in culture and overexpression of stem cell markers. Xenograft experiments in immunodeficient (SCID) mice demonstrate that (1) Bmi-1 overexpression alone in MCF1OA cells cannot induce tumors; (2) H-ras overexpression induces development of tumors with vascular, smooth muscle, and mast cell components; whereas (3) the combination of Bmi-1 and H-Ras induces development of poorly-differentiated aggressive mammary neoplasms with greatly increased propensity for spontaneous distant metastasis to liver, spleen, and brain. Moreover, by using tail vein injection experiments in SCID mice as a model of direct hematogenous spread to the lungs, combination of Bmi-1 and H-ras overexpression in mammary epithelial cells results in fulminant pulmonary metastasis leading to clinical signs of weight loss and dyspnea, whereas injection of cells overexpressing H-ras or Bmi-1 alone does not result in this aggressive metastatic phenotype. Additionally, our data suggests |
|
|
Bone-Modifying Agents in Metastatic Breast Cancer Guidelines Pocketcard: American Society of Clinical Oncology (2011) $6.09 Used – GUIDELINES Pocketcard(TM) is a trifold pocketcard containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students. The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard(TM) is endorsed by the American Society of Clinical Oncology (ASCO) and based on their latest guidelines. This practical quick-reference tool includes timing of the |